Gene · 3860
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide analysis of a cellular exercise model based on electrical pulse stimulation. | Sci Rep | 2022 | 36481702 | PubTator, text mining | PubMed |
| Exaggerated Placental Site as a Cause of Hysterectomy for Massive Bleeding After First Trimester Voluntary Abortion. | J Obstet Gynaecol India | 2022 | 36458070 | PubTator, text mining | PubMed |
| Specific decellularized extracellular matrix promotes the plasticity of human ocular surface epithelial cells. | Front Med (Lausanne) | 2022 | 36457571 | PubTator, text mining | PubMed |
| Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip. | Microbiome | 2022 | 36434666 | PubTator, text mining | PubMed |
| Continuous Monitoring of Suspended Particulate Matter in Tropical Inland Waters by High-Frequency, Above-Water Radiometry. | Sensors (Basel) | 2022 | 36433329 | PubTator, text mining | PubMed |
| Targeting PTEN Regulation by Post Translational Modifications. | Cancers (Basel) | 2022 | 36428706 | PubTator, text mining | PubMed |
| Ciliogenesis is intrinsically altered in COPD small airways. | Eur Respir J | 2022 | 36396143 | PubTator, text mining | PubMed |
| Polymorphisms in the K13-Propeller Gene in Artemisinin-Resistant Plasmodium in Mice. | Infect Drug Resist | 2022 | 36386414 | PubTator, text mining | PubMed |
| Potential of nanoformulations in malaria treatment. | Front Pharmacol | 2022 | 36386185 | PubTator, text mining | PubMed |
| Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance. | Cancer Cell Int | 2022 | 36376983 | PubTator, text mining | PubMed |
| Piezo1-expressing vocal fold epithelia modulate remodeling via effects on self-renewal and cytokeratin differentiation. | Cell Mol Life Sci | 2022 | 36376494 | PubTator, text mining | PubMed |
| Structural Modelling Prediction of Recombinant Plasmodium falciparum K13-F446I and K13-C580Y Gene by AlphaFold Method and Heterologous Expression in Spodoptera frugiperda 9 Cells. | Pathogens | 2022 | 36365022 | PubTator, text mining | PubMed |
| EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms. | Int J Mol Sci | 2022 | 36362433 | PubTator, text mining | PubMed |
| Mutations in the α4-α5 allosteric lobe of RAS do not significantly impair RAS signaling or self-association. | J Biol Chem | 2022 | 36334633 | PubTator, text mining | PubMed |
| FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. | Nat Commun | 2022 | 36323682 | PubTator, text mining | PubMed |
| iPSCs derived from esophageal atresia patients reveal SOX2 dysregulation at the anterior foregut stage. | Dis Model Mech | 2022 | 36317486 | PubTator, text mining | PubMed |
| Age-dependent antibody profiles to plasmodium antigens are differentially associated with two artemisinin combination therapy outcomes in high transmission setting. | Front Med (Lausanne) | 2022 | 36314027 | PubTator, text mining | PubMed |
| Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stages. | PLoS Pathog | 2022 | 36306287 | PubTator, text mining | PubMed |
| Matrix metalloproteinase-7 is increased in lung bases but not apices in idiopathic pulmonary fibrosis. | ERJ Open Res | 2022 | 36299365 | PubTator, text mining | PubMed |
| The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review. | Int J Mol Sci | 2022 | 36293471 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3860/papers?page=20